Acute prostatitis
Methodology & AI Transparency ⓘ
Acute prostatitis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as N41.0, Acute prostatitis falls under Urology & Prostate management, where urinalysis/urine culture [Acute prostatitis N41.0] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Acute prostatitis uses ICD-10 N41.0 across Urology & Prostate specialty care.
- 3 Typical cash cost range: Primary evaluation for Acute prostatitis incorporates urinalysis/urine culture [Acute prostatitis N41.0] and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Acute prostatitis: IPSS Urinary Symptom in Acute prostatitis (N41.0: Score) (0 – 7 (mild symptoms) (N41.0)) and Urinalysis & Post-Void in Acute prostatitis (N41.0: Residual (PVR)).
Ask our AI Specialists anything about Acute prostatitis
What Is Acute prostatitis?
Designated in federal medical registries as N41.0, Acute prostatitis falls under Urology & Prostate management, where urinalysis/urine culture [Acute prostatitis N41.0] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in urology & prostate, Acute prostatitis (N41.0) involves uropathogenic bacterial mucosal in Acute prostatitis (N41.0: adherence (cystitis) or). progression correlates with shifts in IPSS Urinary Symptom in Acute prostatitis (N41.0: Score) (0 – 7 (mild symptoms) (N41.0)).
Common Symptoms & Clinical Signs
- • Presentation of Acute prostatitis (N41.0): sudden severe flank-to-groin in Acute prostatitis (N41.0: colicky pain caused)
- • Secondary Acute prostatitis clinical sign: weak, hesitant, or in Acute prostatitis (N41.0: intermittent urinary stream)
- • Symptom flares in Acute prostatitis correlating with IPSS Urinary Symptom in Acute prostatitis (N41.0: Score) deviation outside 0 – 7 (mild symptoms) (N41.0)
- • Functional urology & prostate impact requiring urinalysis/urine culture [Acute prostatitis N41.0] evaluation (N41.0)
Acute prostatitis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N41.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Prostate (BPH), Bladder & Urinary Tract | NLM Clinical Tables |
| Diagnostic / Lab Marker: IPSS Urinary Symptom in Acute prostatitis (N41.0: Score) | 0 – 7 (mild symptoms) (N41.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urinalysis & Post-Void in Acute prostatitis (N41.0: Residual (PVR)) | Negative leukocyte/nitrite; PVR < 50 mL (N41.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Total PSA & in Acute prostatitis (N41.0: Serum Creatinine/eGFR) | Age-specific PSA; eGFR > 75 mL/min (N41.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Acute prostatitis
Treatment selection for Acute prostatitis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Acute prostatitis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Intermittent or Continuous kidney-Replacement Therapy in Acute Kidney New England Journal of Medicine, Volume 395, Issue 17 , Page 1677-1690, October 29, 2026. New England Journal of Medicine • 2026-10-14 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 97/100 | PMID NEJM-62256824 ↗ |
| New Insights on Baseline data, initial course, and management: losartan versus captopril: What a 5,477-Participant Study Found A total of 5,477 patients with heart failure during the acute phase or with a new Q-wave anterior infarction or reinfarction were recruited. The American journal of cardiology • 2001-03-15 • Randomized Controlled Trial | N = 5,477 | 96/100 | PMID 11249900 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Evaluating the real-world benefits and safety of SpikoGen®, an: What a 4,219-Participant Study Found 12 657 and 4219 participants were randomized to the SpikoGen® and placebo group and followed for a median of 55 days (interquartile range, 48-60 days) and 51 days. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2023-02-15 • Phase III Randomized Trial | N = 4,219 | 96/100 | PMID 36096430 ↗ |
| New Insights on Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney: What a 6,385-Participant Study Found Results showed that statin loading before contrast administration was associated with a significantly reduced risk of CI-AKI in patients with CKD undergoing cardiac catheterization (odds ratio: 0.46; P < .05). Angiology • 2019-04-15 • Meta-Analysis | N = 6,385 | 94/100 | PMID 30261736 ↗ |
Acute prostatitis Patient Community & “People Like Me” Threads
Filter Acute prostatitis community threads and patient logs by age, biological sex, dosage, and treatment duration.